Bio-Rad Laboratories

Bio-Rad Laboratories

Quarterly Financials

Values in thousands2026-06-302026-03-312025-12-312025-09-30
Revenue
$651,000
$592,100
$693,200
$653,000
Gross Profit
345,800
309,400
345,200
343,400
EBITDA
542,100
-636,600
993,700
-364,600
EBIT
-677,500
941,300
-418,800
Net Income
371,400
-527,100
720,000
-341,900
Net Change In Cash
651,000
592,100
693,200
653,000
Free Cash Flow
66,700
78,100
119,100
89,200
Cash
517,000
507,200
531,799
397,800
Basic Shares
26,814
26,958
27,012
26,923

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$2,583,200
$2,566,500
$2,671,262
$2,802,249
Gross Profit
1,343,600
1,378,900
1,426,946
1,567,330
EBITDA
1,249,900
-2,142,000
-654,800
-4,488,959
EBIT
1,044,500
-2,293,600
-800,700
-4,666,159
Net Income
759,900
-1,844,200
-637,324
-3,627,535
Net Change In Cash
2,583,200
2,566,500
2,671,262
2,802,249
Cost of Revenue
-39,570
Free Cash Flow
374,600
266,200
218,263
80,290
Cash
531,799
488,100
403,800
434,215
Basic Shares
27,281
28,214
29,209
29,785

Earnings Calls

QuarterEPS
2026-06-30
$2.62
2026-03-31
$1.89
2025-12-31
$2.51
2025-09-30
$2.26